Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer (opens ClinicalTrials.gov)
- Sponsor
- Pfizer
- Enrolment
- 600
- Started
- 2026-10-14
- Last update
- 2026-10-30
Conditions: Endometrial Neoplasms, Endometrial Cancer
Interventions: PF-08634404, Pembrolizumab, Standard of Care Chemotherapy